HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Narinder Nangia Selected Research

Narinder Nangia Research Topics

Disease

4Opioid-Related Disorders (Opiate Addiction)
12/2020 - 01/2018
3Major Depressive Disorder (Major Depressive Disorders)
01/2020 - 01/2019
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2020 - 01/2018
2Schizophrenia (Dementia Praecox)
01/2020 - 01/2019
1Thrombotic Microangiopathies
01/2022
1Relapsing-Remitting Multiple Sclerosis
11/2020
1Weight Gain
01/2020

Drug/Important Bio-Agent (IBA)

5Buprenorphine (Subutex)FDA LinkGeneric
12/2020 - 01/2019
5Opioid Analgesics (Opioids)IBA
01/2020 - 01/2018
4Naltrexone (ReVia)FDA LinkGeneric
12/2020 - 01/2018
43-carboxamido-4-hydroxynaltrexoneIBA
01/2020 - 01/2019
2Olanzapine (Zyprexa)FDA Link
01/2020 - 01/2019
2Narcotic Antagonists (Opioid Antagonists)IBA
01/2020 - 01/2019
1narsoplimabIBA
01/2022
1Serine (L-Serine)FDA Link
01/2022
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2022
1diroximel fumarateIBA
11/2020
1FumaratesIBA
11/2020
1Delayed-Action PreparationsIBA
01/2020
13,3'- di- (N- cyclopropylmethyl- 4,5- epoxy- 14- hydroxymorphinan- 6- one- 3- yl)carbonateIBA
01/2020
1Moxifloxacin (Avelox)FDA Link
01/2020
1Antipsychotic Agents (Antipsychotics)IBA
01/2020

Therapy/Procedure

2Injections
12/2020 - 01/2018
1Therapeutics
01/2022
1Hematopoietic Stem Cell Transplantation
01/2022